SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-399728
Filing Date
2014-11-06
Accepted
2014-11-06 07:31:38
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d782444d10q.htm 10-Q 1139868
2 EX-21.1 d782444dex211.htm EX-21.1 6847
3 EX-31.1 d782444dex311.htm EX-31.1 9443
4 EX-31.2 d782444dex312.htm EX-31.2 9322
5 EX-32.1 d782444dex321.htm EX-32.1 4664
6 EX-32.2 d782444dex322.htm EX-32.2 4571
  Complete submission text file 0001193125-14-399728.txt   8988667

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hznp-20140930.xml EX-101.INS 1186478
8 XBRL TAXONOMY EXTENSION SCHEMA hznp-20140930.xsd EX-101.SCH 80549
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20140930_cal.xml EX-101.CAL 90290
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20140930_def.xml EX-101.DEF 336580
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20140930_lab.xml EX-101.LAB 635634
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20140930_pre.xml EX-101.PRE 505915
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 141198804
SIC: 2834 Pharmaceutical Preparations